Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ACETAMINOPHEN AND CODEINE PHOSPHATE

ACETAMINOPHEN; CODEINE PHOSPHATE

Standard Dose
325MG;45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ACETAMINOPHEN AND CODEINE PHOSPHATE is listed in Drugs@FDA under application 085363 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength TABLET;ORAL - 325MG;45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor KV PHARM Submission history Latest submission status date: 1998-06-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview ACETAMINOPHEN AND CODEINE PHOSPHATE is listed in Drugs@FDA under application 085363 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CODEINE PHOSPHATE Form and strength TABLET;ORAL - 325MG;45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor KV PHARM Submission history Latest submission status date: 1998-06-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.